The Use of Last-Line Antibiotics for the Treatment of COVID-19 Is a Risk to Disarm Humanity Against Future Antibiotic-Resistant Infectious Diseases

IF 0.4 Q4 INFECTIOUS DISEASES

Infectious Diseases in Clinical Practice Pub Date : 2023-06-27 DOI:10.1097/ipc.0000000000001272

Seyed Soheil Hosseininasab, M. Gorji, Seyyedeh Sanaz Hosseini, M. T. Moghadam

引用次数: 1

查看原文本刊更多论文

使用最后一线抗生素治疗COVID-19是人类抵御未来抗生素耐药性传染病的风险

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infectious Diseases in Clinical Practice INFECTIOUS DISEASES-

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： Medical professionals seeking an infectious diseases journal with true clinical value need look no further than Infectious Diseases in Clinical Practice. Here, clinicians can get full coverage consolidated into one resource, with pertinent new developments presented in a way that makes them easy to apply to patient care. From HIV care delivery to Hepatitis C virus testing…travel and tropical medicine…and infection surveillance, prevention, and control, Infectious Diseases in Clinical Practice delivers the vital information needed to optimally prevent and treat infectious diseases. Indexed/abstracted in: EMBASE, SCOPUS, Current Contents/Clinical Medicine